Center for Scientific Review; Notice of Closed Meetings, 27848-27849 [2017-12591]
Download as PDF
<![CDATA[
27848
Federal Register / Vol. 82, No. 116 / Monday, June 19, 2017 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued
Number of
respondents
Activity
Total ...................................................................
Number of
responses per
respondent
Total annual
responses
Average burden
per response
........................
........................
........................
...................................
Total hours 2
845
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
2 Rounded to the next full hour.
Drug Administration’s Bad Ad Program
and Education Regarding Pharmaceutical
Advertising: A National Survey of
Prescribers in Ambulatory Care
Settings,’’ Journal of Health
Communication, 20:1330–1336, 2015.
II. References
asabaliauskas on DSKBBXCHB2PROD with NOTICES
The following references are on
display in the Dockets Management
Staff (see ADDRESSES) and are available
for viewing by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday; they are also available
electronically at https://
www.regulations.gov. FDA has verified
the Web site addresses, as of the date
this document publishes in the Federal
Register, but Web sites are subject to
change over time.
1. Johar, K., ‘‘An Insider’s Perspective:
Defense of the Pharmaceutical Industry’s
Marketing Practices,’’ Albany Law
Review, 76:299–334, 2012–2013.
2. Wick, C., M. Egger, S. Trelle, et al., ‘‘The
Characteristics of Unsolicited Clinical
Oncology Literature Provided by
Pharmaceutical Industry,’’ Annals of
Oncology, 18:1580–1582, 2007.
3. Fisher, J.A., M.D. Cottingham, and C.A.
Kalbaugh, ‘‘Peering Into the
Pharmaceutical ‘Pipeline’:
Investigational Drugs, Clinical Trials,
and Industry Priorities,’’ Social Science
& Medicine, 131:322–330, 2015.
4. Centerwatch, ‘‘FDA Approved Drugs for
Oncology,’’ https://
www.centerwatch.com/druginformation/fda-approved-drugs/
therapeutic-area/12/oncology (accessed
on March 2, 2017).
5. Pazdur, R., ‘‘Endpoints for Assessing Drug
Activity in Clinical Trials,’’ The
Oncologist, 13:19–21, 2008.
6. Dodge, T. and A. Kaufman, ‘‘What Makes
Consumers Think Dietary Supplements
Are Safe and Effective? The Role of
Disclaimers and FDA Approval,’’ Health
Psychology, 26:513–517, 2007.
7. Dodge, T., D. Litt, and A. Kaufman,
‘‘Influence of the Dietary Supplement
Health and Education Act on Consumer
Beliefs About the Safety and
Effectiveness of Dietary Supplements,’’
Journal of Health Communication,
16:230–244, 2011.
8. Mason, M.J., D.L. Scammon, and X. Fang,
‘‘The Impact of Warnings, Disclaimers,
and Product Experience on Consumers’
Perceptions of Dietary Supplements,’’
The Journal of Consumer Affairs, 41:74–
99, 2007.
9. France, K.R. and P.F. Bone, ‘‘Policy
Makers’ Paradigms and Evidence From
Consumer Interpretations of Dietary
Supplement Labels,’’ The Journal of
Consumer Affairs, 39:27–51, 2005.
10. O’Donoghue, A.C., V. Boudewyns, K.J.
Aikin, et al., ‘‘Awareness of the Food and
VerDate Sep<11>2014
17:09 Jun 16, 2017
Jkt 241001
Dated: June 13, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–12599 Filed 6–16–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Revision Applications for U.S.-South Africa
Program for Collaborative Biomedical
Research.
Date: June 29, 2017.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Name of Committee: AIDS and Related
Research Integrated Review Group; AIDS
Molecular and Cellular Biology Study
Section.
Date: July 10, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AIDS and
Related Research Member Conflict.
Date: July 10, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shalanda A. Bynum,
Ph.D., MPH, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
Bethesda, MD 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 16–
257: Predicting Behavioral Responses to
Population Level Cancer Control Strategies
(R21).
Date: July 11, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Karin F. Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 254–
9975, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 15–
287: Opportunities for Collaborative Research
at the NIH Clinical Center.
Date: July 11, 2017.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Fungai Chanetsa, MPH,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
E:\FR\FM\19JNN1.SGM
19JNN1
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 116 / Monday, June 19, 2017 / Notices
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, 301–408–
9436, fungai.chanetsa@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Digestive Sciences.
Date: July 12, 2017.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Martha Garcia, Ph.D.,
Scientific Reviewer Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186,
MSC 7818, Bethesda, MD 20892, 301–435–
1243, garciamc@nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group; AIDS
Immunology and Pathogenesis Study
Section.
Date: July 12, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Long Beach, 500 East
First Street, Long Beach, CA 90802.
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Biological Chemistry and
Macromolecular Biophysics.
Date: July 12–13, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Urology and
Urogynecology Small Business Applications.
Date: July 12, 2017.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ganesan Ramesh, Ph.D.,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Dr.,
Room 2182, MSC 7818, Bethesda, MD 20892,
301–827–5467, ganesan.ramesh@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Chemical Discovery for Substance Use
Disorders.
Date: July 12, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:09 Jun 16, 2017
Jkt 241001
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Michael Eissenstat, Ph.D.,
Scientific Review Officer, BCMB IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
Bethesda, MD 20892, 301–435–1722,
eissenstatma@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular Genetics.
Date: July 12, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Methode Bacanamwo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200,
Bethesda, MD 20892, 301–827–7088,
methode.bacanamwo@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
390: NIBIB Trailblazer Award for New and
Early Stage Investigators (R21).
Date: July 12–13, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 4128,
Bethesda, MD 20892, 301–435–1850, limc4@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Radiation
Therapy and Biology.
Date: July 13–14, 2017.
Time: 9:00 a.m. to 11:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 13, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12591 Filed 6–16–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
27849
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Environmental Health Sciences Special
Emphasis Panel, June 06, 2017, 08:00
a.m. to June 06, 2017, 06:00 p.m.,
NIEHS/National Institute of
Environmental Health, Keystone
Building, 530 Davis Drive, Research
Triangle Park, NC 27709 which was
published in the Federal Register on
May 26, 2017, 82 FR 24363.
This meeting is being amended to
change the date from Tuesday, June 6,
2017 to Thursday, July 6, 2017, 10:00
a.m. to 10:00 p.m. The meeting is closed
to the public.
Dated: June 13, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12616 Filed 6–16–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; APOL1 Long-term
Kidney Transplantation Outcomes Network.
Date: July 10–11, 2017.
Time: 8:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
E:\FR\FM\19JNN1.SGM
19JNN1
]]>Agencies
[Federal Register Volume 82, Number 116 (Monday, June 19, 2017)]
[Notices]
[Pages 27848-27849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12591]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: Revision Applications for U.S.-South Africa
Program for Collaborative Biomedical Research.
Date: June 29, 2017.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Robert Freund, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, 301-435-
1050, freundr@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: AIDS and Related Research Integrated Review
Group; AIDS Molecular and Cellular Biology Study Section.
Date: July 10, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD
20892, (301) 435-1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AIDS and Related Research Member Conflict.
Date: July 10, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shalanda A. Bynum, Ph.D., MPH, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 301-
755-4355, bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 16-257: Predicting Behavioral Responses to Population
Level Cancer Control Strategies (R21).
Date: July 11, 2017.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Karin F. Helmers, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD
20892, (301) 254-9975, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR 15-287: Opportunities for Collaborative Research at the
NIH Clinical Center.
Date: July 11, 2017.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Fungai Chanetsa, MPH, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
[[Page 27849]]
Health, 6701 Rockledge Drive, Room 3135, MSC 7770, Bethesda, MD
20892, 301-408-9436, fungai.chanetsa@nih.hhs.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Digestive Sciences.
Date: July 12, 2017.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Martha Garcia, Ph.D., Scientific Reviewer
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186, MSC 7818, Bethesda, MD
20892, 301-435-1243, garciamc@nih.gov.
Name of Committee: AIDS and Related Research Integrated Review
Group; AIDS Immunology and Pathogenesis Study Section.
Date: July 12, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard Long Beach, 500 East First Street, Long Beach,
CA 90802.
Contact Person: Shiv A. Prasad, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD
20892, 301-443-5779, prasads@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Biological Chemistry and Macromolecular
Biophysics.
Date: July 12-13, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301-435-1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Urology and Urogynecology Small Business Applications.
Date: July 12, 2017.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ganesan Ramesh, Ph.D., Center for Scientific
Review, National Institutes of Health, 6701 Rockledge Dr., Room
2182, MSC 7818, Bethesda, MD 20892, 301-827-5467,
ganesan.ramesh@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Chemical Discovery for Substance Use Disorders.
Date: July 12, 2017.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael Eissenstat, Ph.D., Scientific Review
Officer, BCMB IRG, Center for Scientific Review, National Institutes
of Health, 6701 Rockledge Drive, Room 4166, Bethesda, MD 20892, 301-
435-1722, eissenstatma@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Molecular Genetics.
Date: July 12, 2017.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Methode Bacanamwo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301-
827-7088, methode.bacanamwo@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-16-390: NIBIB Trailblazer Award for New and Early Stage
Investigators (R21).
Date: July 12-13, 2017.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Chee Lim, Ph.D., Center for Scientific Review,
National Institutes of Health, 6701 Rockledge Drive Room 4128,
Bethesda, MD 20892, 301-435-1850, limc4@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Radiation Therapy and Biology.
Date: July 13-14, 2017.
Time: 9:00 a.m. to 11:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bo Hong, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301-996-
6208, hongb@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 13, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-12591 Filed 6-16-17; 8:45 am]
BILLING CODE 4140-01-P
